Michael G. Risbano
Impact in
- Biochemistry top 5%
- Blood transfusion and management
-
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Pulmonary Hypertension Research and Treatments 17
-
- Blood transfusion and management 2
- Co-authors
- Mark T. Gladwin (3 shared papers)Stephen Y. Chan (9 shared papers)Belinda N. Rivera‐Lebron (4 shared papers)Mehdi syed Nouraie (6 shared papers)Mark W. Geraci (2 shared papers)Christina A. Meadows (2 shared papers)David H. Collier (2 shared papers)Todd M. Bull (3 shared papers)
- Journals
- Pulmonary Circulation (7 papers)CHEST Journal (6 papers)European Respiratory Journal (3 papers)Medical Image Analysis (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesFranceIreland
In The Last Decade
Michael G. Risbano
36 papers receiving 661 citations
Peers
Comparison fields: 5 of 50
- Biochemistry 48
- Pulmonary and Respiratory Medicine 258
- Complementary and alternative medicine 19
- Pathology and Forensic Medicine 39
- Internal Medicine 6
Countries citing papers authored by Michael G. Risbano
This map shows the geographic impact of Michael G. Risbano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Risbano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Risbano more than expected).
Fields of papers citing papers by Michael G. Risbano
This network shows the impact of papers produced by Michael G. Risbano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Risbano. The network helps show where Michael G. Risbano may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael G. Risbano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 64 | |
| 2 | 2015 | 61 | |
| 3 | 2019 | 53 | |
| 4 | 2010 | 51 | |
| 5 | 2024 | 39 | |
| 6 | 2017 | 37 | |
| 7 | 2020 | 37 | |
| 8 | 2019 | 35 | |
| 9 | 2022 | 31 | |
| 10 | 2011 | 29 | |
| 11 | 2013 | 28 | |
| 12 | 2020 | 25 | |
| 13 | 2023 | 25 | |
| 14 | 2024 | 21 | |
| 15 | 2018 | 18 | |
| 16 | 2007 | 16 | |
| 17 | 2019 | 15 | |
| 18 | 2019 | 14 | |
| 19 | 2007 | 12 | |
| 20 | 2024 | 12 |
About Michael G. Risbano
Michael G. Risbano is a scholar working on Pulmonary and Respiratory Medicine, Biochemistry, Complementary and alternative medicine, Neurology and Internal Medicine, having authored 37 papers that have together received 681 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (17 papers), Cardiovascular and exercise physiology (2 papers), Blood transfusion and management (2 papers), Long-Term Effects of COVID-19 (2 papers), Escherichia coli research studies (1 paper), Ethics in Clinical Research (1 paper), Clinical Laboratory Practices and Quality Control (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Biochemistry (48 citations), Pulmonary and Respiratory Medicine (258 citations), Complementary and alternative medicine (19 citations), Pathology and Forensic Medicine (39 citations) and Internal Medicine (6 citations). Michael G. Risbano has collaborated with scholars based in United States, France and Ireland. Frequent co-authors include Mark T. Gladwin, Stephen Y. Chan, Belinda N. Rivera‐Lebron, Mehdi syed Nouraie, Mark W. Geraci, Christina A. Meadows, David H. Collier, Todd M. Bull, Michael A. Mathier and Chenell Donadee. Their work appears in journals such as Pulmonary Circulation, CHEST Journal, European Respiratory Journal, Medical Image Analysis and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.